# Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation

> **NCT02044185** · — · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Acute Graft-versus-host Disease

## Interventions

- **DRUG:** salvage chemotherapy, total body irradiation

## Key facts

- **NCT ID:** NCT02044185
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044185, "Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02044185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*